News

March 29, 2021

1 min read

BioWorld published an article about Leyden Labs raising €40 million in their Series A

Cormac Sheridan wrote an article about our investment round with GV (formerly Google Ventures), F-Prime, Casdin Capital and Brook Byers. To learn more about our Series A and our story, visit the BioWorld website.

Business

March 26, 2021

1 min read

Leyden Labs’ story is covered in Endpoints News

Leading up to the public launch, our CEO Koenraad Wiedhaup spoke with Amber Tong of Endpoints News about Leyden Labs. An interesting read to learn more about our mission to free humanity from the …

Business

March 25, 2021

2 min read

Leyden Labs to Unlock a New Generation of Preventative Medicines against Known and Future Viruses by Securing a €40 Million Series A from GV (formerly Google Ventures), F-Prime and Casdin Capital

Funding to advance platform and portfolio of intranasal products that protect against a broad range of respiratory viruses, including influenza and coronaviruses, to let people live their lives freely

‹ Newer Posts

OUR NEW APPROACH | OUR TEAM | JOIN OUR MISSION | NEWS | CAREERS

Contact

info@leydenlabs.com

Media inquiries

media@leydenlabs.com

Stay updated

Leyden Laboratories B.V.

Leiden Laboratory
Emmy Noetherweg 2
2333 BK Leiden
The Netherlands

Leyden Labs Asia Pte. Ltd.

79 Science Park Drive
#04-05, Cintech IV
Singapore 118264